LEGN
Legend Biotech Corporation · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -9.1% ·
flujo de acciones -10.4% ·
nuevas posiciones netas -10.0%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 91 | +11 | 61.76M | $1.78B | +16 | −5 |
| Q1 2026 | 82 | -3 | 51.41M | $929.52M | +5 | −8 |
| Q4 2025 | 86 | +2 | 50.21M | $1.09B | +2 | — |
| Q3 2025 | 13 | -2 | 38.53M | $1.26B | — | −2 |
| Q2 2025 | 12 | -1 | 34.51M | $1.22B | +1 | −2 |
| Q1 2025 | 10 | 0 | 13.38M | $453.85M | — | — |
| Q4 2024 | 10 | -1 | 15.80M | $514.13M | — | −1 |
| Q3 2024 | 10 | +3 | 16.52M | $804.74M | +3 | — |
| Q2 2024 | 7 | — | 18.35M | $812.58M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.81M | -39.0% | $221.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 6.81M | -39.0% | $221.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.90M | +120.6% | $94.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 2.90M | +120.6% | $94.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.12M | +4.1% | $69.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (pasivo) | 1.12M | — | $36.45M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 908.10K | +4917.1% | $29.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 642.45K | +961.9% | $20.91M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Geode Capital Management ✦ (pasivo) | 519.47K | +5.0% | $16.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 519.47K | +5.0% | $16.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 361.56K | -26.9% | $11.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 361.56K | -26.9% | $11.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 255.47K | -55.2% | $8.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 161.72K | -2.6% | $5.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Point72 Asset Management | $9.52M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 189 tenedores, 95.78M acciones, $1.69B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.